Verified
Abbott
Experimenting- Medical devices and diagnostics
- ~115,000 employees
- CIO Sabina Ewing leads AI
- 8,600+ trained on AI
- No AI return reported
Abbott deploys AI inside the company through its IT organization under CIO Sabina Ewing, where an executive steering committee on generative AI funds a short list of projects. Abbott's GenAI Center of Excellence had trained more than 8,600 employees on AI by Jun 2026. Abbott has built AI into its products for more than 10 years, from FreeStyle Libre to Ultreon imaging software, but reports no business return it credits to AI and no count of employees using its AI tools.
abbott.comTheir approach to AI
- The platform
- Abbott has not named an internal AI platform. Abbott's 2025 Global Sustainability Report (Jun 2026) describes a GenAI Center of Excellence, an AI Governance Council and Microsoft Copilot training. Sabina Ewing said in Jul 2026 that an executive steering committee on generative AI decides where AI capital goes.
- The models
- Abbott trains employees on Microsoft Copilot (Jun 2026) and names no other model provider for internal work. Abbott has not said whose model runs Libre Assist, its generative AI meal feature. Lingo glucose data will feed Google's Health Coach under an Aug 2026 partnership.
- The reach
- More than 8,600 Abbott employees had been trained on AI by Jun 2026, about 7% of the roughly 115,000 staff Abbott employed at Dec 31, 2025. Abbott gives no count of employees who use AI tools.
- The catch
- Abbott reports no business return it credits to AI. Sabina Ewing said in Jul 2026 that she has committed IT to "two commas of results" from new AI operational capabilities, a commitment with no figure, date or outcome attached.
Snapshot
- Employees
- ~115,000 (Dec 2025)
- 69% outside the U.S. (2025 Form 10-K)
- Technology budget
- Not disclosed
- No IT or AI spending figure in the 2025 Form 10-K or 2025 annual report
- AI/ML headcount
- Not disclosed
- Abbott gives no count of AI, data science or data engineering staff
- Who owns AI
- Sabina Ewing, SVP and CIO
- Leads Business and Technology Services; an executive steering committee on generative AI allocates AI capital (Jul 2026)
- Platform
- None named
- GenAI Center of Excellence and Microsoft Copilot training (Jun 2026)
- Models
- Microsoft Copilot
- No other provider named for internal work; Libre Assist's model provider not disclosed
- Reach
- 8,600+ trained on AI
- Jun 2026; no count of employees using AI tools
- Use cases
- Quality risk, talent, IT; AI in products
- No internal use case has a published return
Key findings
Sabina Ewing, Abbott's SVP and CIO, said in Jul 2026 that Abbott set up an executive steering committee on generative AI and applies traditional financial measures to AI investments. Ewing said Abbott is not going out with "a thousand flowers blooming" and that she has committed IT to "two commas of results" from new AI operational capabilities.
Abbott's 2025 Global Sustainability Report (Jun 2026) says Abbott established an AI Governance Council and a Data Use and Ethics Council for all its businesses. The report says Abbott's GenAI Center of Excellence had trained more than 8,600 employees on AI, and that Abbott offered training on Microsoft Copilot and a new course on multi-step and multi-agent workflows in 2025.
Abbott's named internal AI uses are machine learning and AI in quality and regulatory risk identification, an AI avatar for manager training, AI on its career site and AI in talent processes (Jun and Jul 2026). Abbott has published no cost, revenue or headcount figure for any of them.
Abbott's most visible AI is in its products. Abbott launched Libre Assist, a generative AI meal guidance feature, in Jan 2026, and Ultreon 3.0 imaging software was cleared by the FDA by May 2026. Abbott acquired LARALAB, maker of the heart.ai cardiac planning software, in Oct 2025, and an Aug 2026 partnership will feed Lingo glucose data into Google's Health Coach.
CDO Magazine reported on Nov 6, 2026 that Abbott appointed Sonali Mathur, previously Chief Data Governance Officer at Humana, as Global Head of Data and Analytics. Mathur's remit is to build data foundations and speed AI-driven change. Abbott reports no AI user count and no return it credits to AI, which leaves Abbott at Experimenting.
Where Abbott sits
- Stage
- Experimenting
Abbott has reported no business return it credits to AI since May 2025. Abbott's 2025 Form 10-K, its 2025 annual report, its Jan and Apr 2026 earnings calls and its Oct 2026 results release mention AI only in products or as a competitive risk, if at all. CIO Sabina Ewing's Jul 2026 pledge of "two commas of results" from AI in IT is a commitment, not a reported figure. Abbott has not reported a company-wide rollout with a user count either. Abbott's 2025 Global Sustainability Report (Jun 2026) says more than 8,600 employees have been trained on AI and that Abbott offered Microsoft Copilot training, but gives no number of employees using AI tools. Abbott's AI work since May 2025 is on the public record, from its AI Governance Council and GenAI Center of Excellence to Libre Assist and the LARALAB acquisition, so Abbott sits at Experimenting rather than Unknown. A cost, revenue or headcount figure Abbott credits to AI in one use case, or a stated count of employees using its AI tools under a named owner, would move Abbott to Piloting.
How the stages are defined - Ownership
- SVP and CIO Sabina Ewing, with an executive steering committee on generative AI
- Platform
- Bought: No internal platform named; Microsoft Copilot for staff
- Models
- Microsoft Copilot; product models not named
- Hosting
- Not disclosed for internal AI beyond Microsoft Copilot; LibreView product data hosted on AWS
- Reach
- 8,600+ employees trained on AI (Jun 2026); no user count
How they deploy
Few bets, chosen centrally
Sabina Ewing said in Jul 2026 that Abbott established an executive steering committee on generative AI and that senior leaders are engaged in how Abbott deploys AI capital. Abbott is not going out with "a thousand flowers blooming", Ewing said. Ewing said Abbott applies traditional financial measures to AI investments and agrees quantifiable outcomes with the business leaders who request each capability.
IT goes first
Sabina Ewing told CIO.com in Jul 2026 that if she tells Abbott's businesses AI can drive outcomes, IT has to demonstrate it first. Ewing said that is why she has committed to "two commas of results" in IT from new AI operational capabilities. Abbott has not published the figure behind the commitment, its timing or what has been delivered.
Education through the ranks
Sabina Ewing said in Jul 2026 that she led a program to educate Abbott's top leaders on AI foundations. Ewing said Abbott runs a continuous cycle of in-person and virtual AI education for employees. Abbott's 2025 Global Sustainability Report (Jun 2026) puts the number of employees trained on AI at more than 8,600 and says the 2025 courses covered Microsoft Copilot, advanced prompting for multi-step workflows and simple multi-agent workflows.
AI as a companion to staff
Sabina Ewing said in Jul 2026 that Abbott asked its executive assistants how they could use AI as a companion to their work, not a replacement for it. Ewing said today's models lack the judgment and institutional knowledge the job needs. Abbott's 2025 Form 10-K and its Jan and Apr 2026 earnings calls do not tie headcount changes to AI.
One set of principles for products and operations
Abbott applies one set of published AI principles to the AI in its products and to the AI it uses to run the company.
- Deployment model
- Abbott runs enterprise AI from Business and Technology Services, the IT organization led by SVP and CIO Sabina Ewing. Ewing's strategic pillars are modernization, enterprise and product cybersecurity, digitization and advanced analytics (Jul 2026). An executive steering committee on generative AI chooses which AI investments go ahead. Abbott's 2025 Global Sustainability Report (Jun 2026) adds an AI Governance Council and a Data Use and Ethics Council covering all Abbott businesses, plus a GenAI Center of Excellence that runs an AI talent and acumen program. Abbott's product businesses build AI into their own devices and apps, such as Libre Assist in diabetes care and Ultreon in vascular, under the same AI principles. Abbott has not published which internal tools, beyond Microsoft Copilot, its employees use.
- Model providers
- Abbott names Microsoft Copilot as an AI tool it trains employees on (2025 Global Sustainability Report, Jun 2026) and has named no other model provider for internal work. Abbott says Libre Assist uses generative AI but has not said whose model it runs. Under an Aug 11, 2026 partnership, Lingo glucose data will feed Google's Health Coach in the Google Health app, which the release ties to Gemini features. Abbott acquired LARALAB, maker of the heart.ai cardiac planning software, in Oct 2025, and has worked with iCardio.ai on AI for its EnSite X electrophysiology mapping system since Sep 2024.
- Data and infrastructure
- Abbott has not said where its internal AI runs, which cloud providers host it or what data employees may give AI tools. For products, Abbott's FreeStyle Libre pages say LibreView data sits in an encrypted SQL Server database hosted by Amazon Web Services, on EU servers for users in Austria. Abbott says AWS cannot read the data. LARALAB's heart.ai is cloud-based software, according to Dechert's Oct 2025 note on the sale, which does not name the cloud. Abbott's 2025 Form 10-K says its Chief Information Security Officer reports to the CIO, who has overall responsibility for cybersecurity. CDO Magazine reported in Nov 2026 that Sonali Mathur's Data and Analytics Office will build Abbott's data foundations for AI.
Platforms and internal tools
GenAI Center of ExcellenceBy Jun 2026
Abbott's GenAI Center of Excellence builds an AI talent and acumen program for employees and had trained more than 8,600 of them on AI by Jun 2026, according to the 2025 Global Sustainability Report. Abbott has not said who leads the GenAI Center of Excellence, how large it is or whether it builds AI applications.
- Users
- 8,600+ trained (Jun 2026)
Microsoft CopilotTraining offered in 2025
Abbott offered employees training on AI and Microsoft Copilot in 2025 and launched a course on advanced prompting to orchestrate multi-step workflows and design simple multi-agent workflows. Abbott has not said how many employees hold Copilot licenses or use it.
- Models
- Microsoft Copilot
Libre AssistJan 5, 2026
Libre Assist is a customer-facing feature in Abbott's Libre app that uses generative AI to predict how a meal may affect a person's glucose. Libre Assist rates the impact by color, suggests changes and then shows the actual glucose response from the FreeStyle Libre sensor. Abbott offers Libre Assist at no extra cost and warns that generative AI may not always be accurate.
- Models
- Generative AI; provider not disclosed
Ultreon 3.0Cleared by May 2026
Ultreon 3.0 is Abbott's customer-facing coronary imaging software. Ultreon 3.0 uses AI on optical coherence tomography images to assess the type of plaque in a blockage and help interventional cardiologists choose stent size and position. Cardiac Interventions Today reported on May 1, 2026 that Ultreon 3.0 had received FDA clearance and CE Mark approval. The first Ultreon software launched in 2021.
heart.ai (LARALAB)Acquired Oct 2025
heart.ai is LARALAB's automated, cloud-based software for pre-screening and planning transcatheter heart valve procedures. Abbott acquired LARALAB, a Munich startup, in Oct 2025, and Robert Ford said in Jan 2026 that Abbott is integrating LARALAB into its structural heart products for pre-procedure planning.
Vendors and partners
MicrosoftBy 2025
Microsoft Copilot, the AI assistant Abbott trains employees on · Abbott's 2025 Global Sustainability Report (Jun 2026) says Abbott continued offering training on AI and Microsoft Copilot in 2025. Abbott has not announced a Copilot deployment size.
Google HealthAug 2026
Product partner: Lingo glucose data in the Google Health app and Google's Health Coach · The multi-year partnership includes a large real-world metabolic health study whose results will inform Google's AI coaching and future Lingo features. Health Coach requires a Google Health Premium subscription.
LARALABOct 2025
Acquired AI cardiac imaging company, maker of heart.ai · Dechert advised LARALAB's shareholders on the sale, announced Oct 22, 2025.
iCardio.aiSep 2024
Product partner for AI on intracardiac echo images in the EnSite X mapping system
Amazon Web Services
Cloud host for LibreView, Abbott's diabetes data platform · Abbott's FreeStyle Libre pages name AWS as the cloud hosting provider for LibreView. Abbott has not said whether AWS also runs any of its AI.
SmartBots AI2018
Built Maya, the virtual assistant for Abbott India's pharmaceutical sales force · Abbott has not reported on Maya since Feb 2019.
Leadership
AI, data and platform leaders
Executives
AI org map
CIO-led enterprise AI under an executive generative AI steering committee; product AI built in the businesses
Abbott's enterprise AI runs through Business and Technology Services under SVP and CIO Sabina Ewing, with capital decisions taken by an executive steering committee on generative AI (Jul 2026). Abbott's 2025 Global Sustainability Report (Jun 2026) adds an AI Governance Council and a Data Use and Ethics Council for all Abbott businesses, plus a GenAI Center of Excellence. CDO Magazine reported in Nov 2026 that Sonali Mathur leads a Data and Analytics Office. Abbott's product businesses, such as diabetes care and vascular, develop the AI in their own devices and apps.
Abbott has not disclosed how many AI, data science or data engineering staff it employs. Abbott's AI work sits in Business and Technology Services under CIO Sabina Ewing and in a Data and Analytics Office led by Sonali Mathur, whose appointment CDO Magazine reported in Nov 2026. The GenAI Center of Excellence runs Abbott's AI talent program, and the product businesses build AI into devices and apps. Abbott's 2025 Global Sustainability Report (Jun 2026) also says its Quality and Regulatory and advanced analytics teams increasingly use machine learning and AI.
Reporting lines
Chairman and CEO
Robert Ford
Business and Technology Services
Sabina Ewing, SVP and CIO
Reporting line not published; Ewing is not listed among Abbott's executive officers in the 2025 Form 10-K
AI Governance Council and Data Use and Ethics Council
Cover all Abbott businesses (Jun 2026); the reporting line is not published and is placed under IT here as an assumption
GenAI Center of Excellence
Runs the AI talent and acumen program, 8,600+ employees trained (Jun 2026); reporting line not published
Data and Analytics Office
Sonali Mathur
Reporting line not published; CDO Magazine, Nov 2026
Cybersecurity
Chief Information Security Officer
The Chief Information Security Officer reports to the CIO (2025 Form 10-K)
Executive Steering Committee on Generative AI
Senior leaders who decide where AI capital goes (Sabina Ewing, Jul 2026); chair, members and reporting line not published
Product businesses
Diabetes care, vascular, structural heart, electrophysiology and others build AI into products such as Libre Assist, Ultreon and heart.ai
Abbott has not published an org chart for AI. Sabina Ewing's Abbott biography says she leads technology strategy, policy and capabilities across the enterprise. Abbott's 2025 Form 10-K does not list Ewing among its executive officers or give her reporting line. CDO Magazine's Nov 2026 report on Sonali Mathur does not say to whom the Data and Analytics Office reports.
Where the AI workforce sits
Business and Technology Services, data and analytics
Abbott publishes no count of its AI, data and analytics staff.
Not disclosedProduct businesses (devices, diagnostics, diabetes care)
Abbott publishes no count of engineers working on AI in its products.
Not disclosed
Named people
Use cases
Abbott has named a handful of internal AI uses: machine learning and AI in quality and regulatory risk identification, Microsoft Copilot and AI training for employees, and an AI avatar in manager training. Abbott has also named an AI chatbot on its career site, AI in talent processes and new AI operational capabilities in IT. Abbott has published no cost, revenue or headcount return for any of them, and no firm-level figure it credits to AI. Abbott describes its customer-facing AI, from Libre Assist to Ultreon 3.0 and heart.ai, in product releases without sales figures credited to AI.
| Use case | Area | Status | ROI |
|---|---|---|---|
| Quality risk identification Abbott's Quality and Regulatory and advanced analytics teams increasingly use machine learning and AI to modernize risk identification and support data analysis and decision-making in Abbott's quality management system. | Quality and Regulatory | In production | |
| Microsoft Copilot and AI training Abbott trains employees on AI and Microsoft Copilot through a GenAI Center of Excellence that had trained more than 8,600 employees by Jun 2026. Abbott's 2025 courses included advanced prompting for multi-step workflows and simple multi-agent workflows. | Firmwide | In production | |
| AI avatar for manager training Abbott's manager development program has participants practice giving feedback and holding difficult conversations with an interactive AI avatar. | Human resources | In production | |
| Career site and talent processes Abbott's career site uses AI to tailor content for applicants and runs a personalized chatbot that helps them identify roles. Sabina Ewing said in Jul 2026 that Abbott has embedded AI into its talent processes. | Human resources | In production | |
| AI operational capabilities in IT Sabina Ewing said in Jul 2026 that she has committed Abbott's IT organization to "two commas of results" from new AI operational capabilities. Ewing did not say which capabilities, by when, or what has been delivered. | Information technology | Announced | |
| Libre Assist meal guidance Libre Assist, launched on Jan 5, 2026 inside the Libre app, uses generative AI to predict a meal's glucose impact from a photo of the meal. Libre Assist suggests changes and confirms the impact with FreeStyle Libre sensor data. | Diabetes care (product) | In production | |
| Ultreon 3.0 coronary imaging Ultreon 3.0 uses AI on optical coherence tomography images to classify plaque and guide stent sizing and placement during coronary procedures. Ultreon 3.0 received FDA clearance and CE Mark approval by May 2026. | Vascular (product) | In production | |
| heart.ai procedure planning Abbott is integrating LARALAB's heart.ai, automated cloud-based software for pre-screening transcatheter valve procedures, into its structural heart products for pre-procedure planning (Robert Ford, Jan 2026). | Structural heart (product) | In production | |
| Lingo glucose data in Google Health Abbott and Google Health will bring Lingo glucose trends into the Google Health app, where Google's Health Coach turns them into personalized recommendations, with integrations rolling out later in 2026. | Lingo (product) | Announced |
Adoption
Abbott measures the spread of AI among employees by training, not use. Abbott's 2025 Global Sustainability Report (Jun 2026) says more than 8,600 employees had been trained on AI through the GenAI Center of Excellence's talent and acumen program, about 7% of the roughly 115,000 staff at Dec 31, 2025. The report says Abbott also offered Microsoft Copilot training in 2025. Abbott has not published how many employees have access to or use Copilot or any other AI tool. Abbott's earlier enterprise AI on record is Maya, a virtual assistant built with SmartBots AI for Abbott India's pharmaceutical sales force. Abbott India piloted Maya with about 3,000 sales staff from early 2018, and Abbott has not reported on Maya since Feb 2019.
By the numbers
Rollout, first pilot to today
Early 2018
Abbott India's pharmaceuticals division began piloting Maya, a virtual assistant built with SmartBots AI, with about 3,000 sales employees.
Feb 2019
BioVoice reported that Maya had handled close to 12,000 queries and that 69% of Abbott India's field force rated it helpful.
Nov 2020
Sabina Ewing joined Abbott from Pfizer as CIO and head of Business and Technology Services.
Oct 2025
Abbott acquired LARALAB, the Munich maker of the heart.ai cardiac planning software.
Jan 2026
Abbott launched Libre Assist, a generative AI meal guidance feature in the Libre app, at CES 2026.
Jun 2026
Abbott's 2025 Global Sustainability Report said Abbott had established an AI Governance Council, a Data Use and Ethics Council and a GenAI Center of Excellence. The report said Abbott had trained more than 8,600 employees on AI and offered Microsoft Copilot training.
Jul 2026
Sabina Ewing described Abbott's executive steering committee on generative AI and her commitment to "two commas of results" from AI in IT.
Nov 2026
CDO Magazine reported that Sonali Mathur had joined Abbott as Global Head of Data and Analytics to lead its Data and Analytics Office.
Economics & controls
Spend and ROI
Technology budget
Abbott does not disclose its technology or AI spending. Abbott's 2025 Form 10-K and 2025 annual report give no IT budget. Sabina Ewing said in Jul 2026 that she works with Abbott's HR and finance leaders to secure AI investment and keep financial discipline where it is spent.
What AI itself costs
Abbott has not published what AI costs, how many AI licenses it buys or what it pays model providers.
Reported ROI
Abbott has reported no business return it credits to AI, at firm level or for any use case. Sabina Ewing said in Jul 2026 that Abbott applies traditional financial measures to AI investments and identifies quantifiable outcomes before funding them. Ewing said she has committed IT to "two commas of results" from new AI operational capabilities, but Abbott has published neither the target nor any result against it.
Productivity and headcount
Abbott employed about 115,000 people at Dec 31, 2025, before adding Exact Sciences in Mar 2026. Abbott's 2025 Form 10-K and its Jan and Apr 2026 earnings calls do not tie headcount changes to AI. Sabina Ewing said in Jul 2026 that Abbott treats AI as a companion to employees' work, not a replacement, using its executive assistants as the example.
Governance and risk
Councils and a steering committee
Abbott's 2025 Global Sustainability Report (Jun 2026) says Abbott established an AI Governance Council and a Data Use and Ethics Council for all its businesses. Sabina Ewing said in Jul 2026 that an executive steering committee on generative AI, with senior leaders engaged, decides how Abbott deploys capital on AI.
Published AI principles
Abbott's approach to AI rests on 5 principles: responsible, safe, transparent, fair and impactful. Abbott commits to human oversight and accountability and to testing AI systems internally and with outside partners where useful before deployment. Abbott also commits to representative data sets that limit bias, to telling people how it uses AI and their data, and to never using AI in a way that could harm product quality or safety.
Medical technology advice
Abbott's Medical Technology Advisory Council, a group of outside advisors, advises Abbott on integrating emerging technologies such as agentic AI and intelligent biosensors across its devices, nutrition platforms and diagnostics (Jun 2026).
Cybersecurity oversight
Abbott's 2025 Form 10-K says the Audit Committee hears from the CIO and the Chief Information Security Officer twice a year on cybersecurity and that the Public Policy Committee oversees product cybersecurity. The Chief Information Security Officer reports to the CIO. The Form 10-K also lists disruptive technologies such as artificial intelligence among the competitive risks that could reduce demand for some Abbott products.
Product disclaimers
Abbott tells Libre Assist users that generative AI may not always be accurate. Abbott's AI principles frame product AI as decision support under scientific standards and human oversight.
Recent signals
Nov 6, 2026
CDO Magazine reported that Abbott appointed Sonali Mathur, previously Chief Data Governance Officer at Humana, as Global Head of Data and Analytics, leading the Data and Analytics Office and accelerating AI-driven transformation.
Aug 11, 2026
Abbott and Google Health announced a multi-year partnership to bring Lingo glucose data into the Google Health app and Google's Health Coach, with a large real-world metabolic health study.
Jul 29, 2026
Sabina Ewing told CIO.com that Abbott has an executive steering committee on generative AI and applies traditional financial measures to AI investments. Ewing said she has committed IT to "two commas of results" from AI.
Jun 2026
Abbott's 2025 Global Sustainability Report said more than 8,600 employees had been trained on AI and described a new AI Governance Council, Data Use and Ethics Council and GenAI Center of Excellence.
May 1, 2026
Cardiac Interventions Today reported that Abbott received FDA clearance and CE Mark approval for Ultreon 3.0, its AI-powered coronary imaging software.
Feb 20, 2026
Abbott's 2025 Form 10-K named disruptive technologies such as artificial intelligence among competitive risks and reported about 115,000 employees at Dec 31, 2025.
Jan 22, 2026
Robert Ford said on Abbott's fourth-quarter call that Abbott is integrating LARALAB, an AI-powered cardiac imaging company it acquired, into its structural heart products for pre-procedure planning.
Jan 5, 2026
Abbott launched Libre Assist, a free generative AI feature in the Libre app that predicts how a meal will affect glucose, at CES 2026.
Quick answers
- How does Abbott deploy AI?
- Abbott deploys AI inside the company through its IT organization under CIO Sabina Ewing, where an executive steering committee on generative AI funds a short list of projects. Abbott's GenAI Center of Excellence had trained more than 8,600 employees on AI by Jun 2026. Abbott has built AI into its products for more than 10 years, from FreeStyle Libre to Ultreon imaging software, but reports no business return it credits to AI and no count of employees using its AI tools.
- What does Abbott use AI for?
- Abbott has named a handful of internal AI uses: machine learning and AI in quality and regulatory risk identification, Microsoft Copilot and AI training for employees, and an AI avatar in manager training. Abbott has also named an AI chatbot on its career site, AI in talent processes and new AI operational capabilities in IT. Abbott has published no cost, revenue or headcount return for any of them, and no firm-level figure it credits to AI. Abbott describes its customer-facing AI, from Libre Assist to Ultreon 3.0 and heart.ai, in product releases without sales figures credited to AI.
- Who leads AI at Abbott?
- AI at Abbott is led by Sabina Ewing (Senior Vice President, Business and Technology Services and Chief Information Officer); Sonali Mathur (Global Head of Data and Analytics). Ownership of AI on the org chart: SVP and CIO Sabina Ewing, with an executive steering committee on generative AI.
- What AI platform does Abbott use?
- Abbott has not named an internal AI platform. Abbott's 2025 Global Sustainability Report (Jun 2026) describes a GenAI Center of Excellence, an AI Governance Council and Microsoft Copilot training. Sabina Ewing said in Jul 2026 that an executive steering committee on generative AI decides where AI capital goes.
- Which AI models does Abbott use?
- Abbott trains employees on Microsoft Copilot (Jun 2026) and names no other model provider for internal work. Abbott has not said whose model runs Libre Assist, its generative AI meal feature. Lingo glucose data will feed Google's Health Coach under an Aug 2026 partnership.
- How many Abbott employees use AI?
- More than 8,600 Abbott employees had been trained on AI by Jun 2026, about 7% of the roughly 115,000 staff Abbott employed at Dec 31, 2025. Abbott gives no count of employees who use AI tools.
- What return has Abbott reported from AI?
- Abbott has reported no business return it credits to AI since May 2025. Abbott's 2025 Form 10-K, its 2025 annual report, its Jan and Apr 2026 earnings calls and its Oct 2026 results release mention AI only in products or as a competitive risk, if at all. CIO Sabina Ewing's Jul 2026 pledge of "two commas of results" from AI in IT is a commitment, not a reported figure. Abbott has not reported a company-wide rollout with a user count either. Abbott's 2025 Global Sustainability Report (Jun 2026) says more than 8,600 employees have been trained on AI and that Abbott offered Microsoft Copilot training, but gives no number of employees using AI tools. Abbott's AI work since May 2025 is on the public record, from its AI Governance Council and GenAI Center of Excellence to Libre Assist and the LARALAB acquisition, so Abbott sits at Experimenting rather than Unknown. A cost, revenue or headcount figure Abbott credits to AI in one use case, or a stated count of employees using its AI tools under a named owner, would move Abbott to Piloting.
Open questions
- What figure stands behind Sabina Ewing's commitment to "two commas of results" from AI in Abbott's IT organization, by when, and what has been delivered so far?
- How many Abbott employees have access to and use Microsoft Copilot or any other AI tool, given that Abbott reports only that more than 8,600 have been trained on AI?
- Which model providers and clouds run Abbott's internal AI, and whose model powers Libre Assist?
- What do Abbott's deployed internal uses, such as machine learning in quality risk identification, the AI career site chatbot and AI in talent processes, return in cost, capacity or headcount?
- Who chairs Abbott's executive steering committee on generative AI and its AI Governance Council, and to whom do the GenAI Center of Excellence and Sonali Mathur's Data and Analytics Office report?
- How much does Abbott spend on technology and on AI, and how many AI and data specialists does it employ?
- Is Maya, the sales assistant Abbott India piloted from 2018, still in use, and has it moved to generative AI?
- Will Abbott report any sales or margin effect from AI features such as Libre Assist and Ultreon 3.0, or from the Google Health partnership?
Sources
Abbott
- Abbott and responsible AI
- Sabina Ewing, SVP Business and Technology Services and CIO, biography
- Robert B. Ford, Chairman and CEO, biography
- Abbott 2025 Global Sustainability Report (Jun 2026)
- Abbott launches Libre Assist (Jan 5, 2026)
- Abbott and Google launch partnership on glucose insights and AI (Aug 11, 2026)
- FreeStyle Libre Austria imprint, LibreView hosting on AWS
Filings and investor materials
Partners
News
- CIO.com: Exploring Abbott's mission-led AI strategy, Sabina Ewing interview (Jul 29, 2026)
- CDO Magazine: Abbott appoints Sonali Mathur Global Head of Data and Analytics (Nov 6, 2026)
- CDO Magazine: This week's leadership moves, Abbott, Commvault and Michigan Medicine (Nov 6, 2026)
- Cardiac Interventions Today: Ultreon 3.0 receives FDA clearance and CE Mark (May 1, 2026)
- BioSpectrum India: Abbott launches AI assistant for its field force (Feb 19, 2019)
- BioVoice: Maya, Abbott's AI personal assistant for its sales force (Feb 19, 2019)
Data confidence
- Confirmed
- Stated in a primary or reputable public source.
- Estimated
- Derived or approximated from public reporting.
- Unconfirmed
- Reported, but not yet corroborated.
Abbott profile · Enterprise AI diffusion report by Imagine · facts checked against their sources on Nov 9, 2026
